Clinical Trial Update: A Study of Ivonescimab in People With Endometrial and Cervical Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Ivonescimab in patients with endometrial cancer and cervical cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Endometrial Cancer, Cervical Cancer | Phase 2 | Status: RECRUITING